Researching potential new treatments for people with NASH
Nepean Blue Mountains Local Health District is conducting a clinical trial to investigate potential new treatment methods for those with NASH, a severe form of non-alcoholic fatty liver disease.
Chronic liver disease is increasing globally due to the emerging rates of obesity, metabolic syndrome, and diabetes mellitus leading to increased incidence of non-alcoholic fatty liver disease (NAFLD).
The trial hopes to gain a better understanding into the prevention of long-term liver damage and how to slow down the progression of the disease.
You, or someone you know, may be able to take part in the study if you/they:
- diagnosed with NASH
- are 18 – 65 years of age
- have a body mass index (BMI) between 18 and 40kg/ m2
There may also be additional requirements to be able to take part.
If you agree to take part, you will be in this study for approximately 1.5 to 2 months. The study will take place at Nepean Hospital and will involve:
- A screening visit (2 – 3 hours) within 28 days of the study treatment
- Outpatient visits on Day -1, Day 1, 2, 7, 14, 21, 28, 29 and 30 (approximately 1-2 hours, except Day 7 which will be approximately 6 hours)
- Day 33 follow-up visit (approximately 1-2 hours)
If this is you please call 0247342435 or email Anjla Devi Anjla.Devi@health.nsw.gov.au for further information and to discuss your eligibility.
You will be eligible for reimbursement of your time and travel. Please discuss this with the team for details.
The trial has been approved by review boards which have been formally designated to protect the rights, safety, and wellbeing of participants.